Status:

RECRUITING

A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Neoplasm Malignant

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Researchers want to learn if MK-1084 given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many peo...

Eligibility Criteria

Inclusion

  • The main inclusion criteria include but are not limited to the following:
  • Has locally advanced unresectable or metastatic solid tumor malignancy other than colorectal cancer and has progressed on, or following, standard of care systemic treatment
  • Has a tumor that demonstrates the presence of Kirsten rat sarcoma (KRAS) G12C mutation

Exclusion

  • The main exclusion criteria include but are not limited to the following:
  • Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
  • Has known additional malignancy that is progressing or has required active treatment within the past 3 years
  • Has known active central nervous system metastases and/or carcinomatous meningitis and/or primary brain tumors
  • Has active infection, other than those permitted per protocol, requiring systemic therapy
  • Has not adequately recovered from major surgery or has ongoing surgical complications

Key Trial Info

Start Date :

December 4 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 9 2032

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT07209111

Start Date

December 4 2025

End Date

April 9 2032

Last Update

January 5 2026

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Greater Baltimore Medical Center ( Site 1104)

Baltimore, Maryland, United States, 21204

2

START Midwest ( Site 1103)

Grand Rapids, Michigan, United States, 49546

3

START Mountain Region ( Site 1106)

West Valley City, Utah, United States, 84119

4

Odense Universitetshospital ( Site 1401)

Odense, Region Syddanmark, Denmark, 5000